Morphological Features of Wound Regeneration in the Local Application of Recombinant Interferon Α2b in the Experiment


Cite item

Abstract

Summery. Introduction. The research devoted to the study of pathogenetic, immunological, and biophysical aspects of the tissue regeneration process with wound defects of various etiologies is gaining in popularity in the "world" of medical science, at present this problem remains topical [1, 2, 6, 8, 9]

Purpose of the study. A comparative analysis of the dynamics of morphological manifestations of tissue regeneration occurring when recombinant interferon α2b, is used in the healing of an acute experimental wound is carried out.

Materials and methods. Depending on the nature of the wound treatment, the experimental animals were divided into two groups: 1) a comparison group in which the edges of the wound were struck with a 0.9% NaCl solution; 2) the main group, where a similar edge of the wound defect was cut off with recombinant interferon α2b at a dose of 1000 ME / 1ml diluted with 0.9% NaCl solution. The rats were removed from the experiment on the 4th, 8th and 20th day of the study, while a full-thickness skin flap was taken in the area of the scar (defect), which was examined by light microscopy. At the same time, the intensity of formation of the granulation tissue, its "maturation", and also in the margins and on the bottom of the wound was estimated in the absolute values, the cellular populations realizing the process of inflammation were determined.

As a result of the study, the character of the complex effect of recombinant interferon α2b was established, which included reduction of the negative effect of secondary alteration, differentiation of the intravascular immune response, formation of conditions for natural regeneration with activation of angiogenesis and synthesis of a valuable scar, decrease in propensity to keloidosis.

Conclusions. The obtained results testify to the morphological validity of the use of recombinant leukocyte interferon α2β as a stimulant of the inflammation phase, as against the background of the use of this substance, its ability to enhance phagocytosis was noted.

About the authors

Ruslan Zhmailik

Volkovysk Central Regional Hospital

Author for correspondence.
Email: Ruslan15_92@mail.ru

Surgeon of the surgical department of Volkovysk CRH

Belarus, 220056, Belarus, Minsk Heroes of the 120th Division 27-20

Vasiliy Bogdan

Military Medical Faculty at the Belarusian State Medical University

Email: bogdan-5@mail.ru

Doctor of Medical Sciences, Professor, Head of the Military Medical Faculty at the Belarusian State Medical University

Belarus, 220019, Belarus, Minsk, ul. Skripnikova 14-49.

Yulia Korneva

1. Smolensk State Medical University
2.  Smolensk Regional Institute of Pathology

Email: ksu1546@yandex.ru

1 PhD, assistant professor of pathological anatomy;

2. The doctor-pathologist, Department of Clinical Pathology № 2

Russian Federation, 214019, Russia, , Smolensk, Krupskaya St., 28  

Alexandr Dorosevich

1. Smolensk State Medical University
2.  Smolensk Regional Institute of Pathology

Email: OGUZSOIP@yandex.ru

MD, Professor, Head of the Department of Pathological Anatomy Medical University "Smolensk State Medical University" of Ministry of Health of Russia;

Russian Federation, 214018, Russia, Smolensk, Gagarina St., 27

References

  1. Abaev U. K. Spravochnik khirurga. Rany i ranevaya infektsiya [Surgeon's Handbook. Wounds and wound infection]. Rostov: Fenix, 2006; 427 (in Russ.)
  2. Evteev A. A., Turnikov U. I. Neudachi autodermoplastiki[Failures of autodermoplasty]. M.: RA ILF, 2011; 160 (in Russ.)
  3. Ershov F. I. Narovlyanskiy A. N. Osnovnyye itogi izucheniya sistemy interferona k 2011 godu. Interferon-2011: sbornik naychnyh statey [The main results of the study of the interferon system by 2011. Interferon-2011: a collection of scientific articles], 2011; 14-34 (in Russ)
  4. Zverev V. V. Meditsinskaya mikrobiologiya, virusologiya i immunologiya [Medical microbiology, virology and immunology]. M.: GEOTAR-Media, 2010; 445 (in Russ.)
  5. Kovalchuk L. V., Ignatieva G. A., Gankovskaya L. V. Immunologia [Immunology]. M.: GEOTAR-Media, 2012; 640 (in Russ)
  6. Kuzin M. I. Patogenez ranevogo protsessa i obshchiye printsipy lecheniya ran. Sovremennyye metody aktivnogo khirurgicheskogo lecheniya gnoynykh ran i ostrykh gnoynykh khirurgicheskikh zabolevaniy [Pathogenesis of the wound process and general principles of wound healing. Modern methods of active surgical treatment of purulent wounds and acute purulent surgical diseases], 1990; 1-6 (in Russ.)
  7. Lisyanyi N.I., Semenova M.V., Lyubich L.D. Dostizheniya i problemy primeneniya interferonov v neyroonkologii. Ukrainskiy neyrokhirurgicheskiy zhurnal [Achievements and problems of interferon application in neurooncology. Ukrainian Neurosurgical Journal]. 2004; 3: 29-36 (in Russ.)
  8. Arias J.I., Aller M.A., Arias J. Surgical inflammation: a pathophysiological rainbow. J Transl Med, 2009; 7: 19.
  9. Kwan P., Hori K., Ding J., Tredget E.E. Scar and contracture: biological principles. HandClin, 2009; 25: 511-528.
  10. Kawasumi A., Sagawa N., Hayashi S., Yokoyama H., Tamura K. Wound healing in mammals and amphibians: Towards limb regeneration in mammals. Curr Top Microbial Immunol, 2013; 367: 33-49.
  11. Leung A., Crombleholme T.M., Keswani S.G. Fetal wound healing: implications for minimal scar formation. Cur rOpin Pediatr, 2012; 24: 371-378.
  12. Profyris C., Tziotzios C., Do Vale I. Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics. Part I. The molecular basis of scar formation. J Am AcadDermatol, 2012; 66: 1-10.
  13. Reinke J.M., Sorg H. Wound repair and regeneration. EurSurg Res, 2012; 49: 35-43.
  14. William E. Fundamental immunology. 7th editor, 2013: 1828.

Supplementary files

There are no supplementary files to display.


Copyright (c) 2017 Zhmailik R., Bogdan V., Korneva Y., Dorosevich A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies